Wednesday 28 July 2021

Global Pipettes, Pipettors, and Accessories Market 2020: Key Companies Profile, Their Market Share And Growth Insights To 2027

 Global pipettes, pipettors, and accessories market is anticipated to register a healthy CAGR over the forecast period. The market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% during the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. Factors driving the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality in healthcare companies, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, as per the data published by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2016 there were 6,861 drug entities in the preclinical regulatory phase that grew to 7,493 in 2017. In contrast, rapid development and launches of automatic and robotic-assisted liquid handling workstations are anticipated to restrain the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7015

Segmentation

The global pipettes, pipettors, and accessories market has been segmented into product and end user.

By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.

Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.

The global pipettes, pipettors, and accessories market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pipettes, pipettors, and accessories market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European pipettes, pipettors, and accessories market has been segmented into Western Europe and Eastern Europe. The Western Europe pipettes, pipettors, and accessories market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The pipettes, pipettors, and accessories market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pipettes, pipettors, and accessories market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Thermo Fisher Scientific Inc., BRAND GMBH + CO KG, CAPP ApS, Thomas Scientific, Inc., Corning Incorporated, Eppendorf AG, Gilson Incorporated, Hamilton Company, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc. are some of the major players in the global pipettes, pipettors, and accessories market.

Regional Market Summary

Geographically, in 2017, the Americas commanded the global pipettes, pipettors, and accessories market due to the presence of pipettes & pipettors manufacturers, advanced technology used in medical devices, rising spending on healthcare, and mounting demand for these lab supplies in the US and Canada.

Europe is also expected to hold substantial market share over the forecast period due to the rise in research & development activities, the presence of favorable government policies related to healthcare infrastructure, the availability of well-developed lab facilities, and early adoption of novel technologies.

Asia-Pacific is likely to witness fastest CAGR from 2018 to 2023 attributed to increased burden of various diseases coupled with considerable funding support for clinical research and rising interest in scientific & industrial research to create new business opportunities.

The market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.

No comments:

Post a Comment